MerwinFRichardMD

PubMed

• 41 citations
  The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration
  Jonathan D. Marmur, Sunil X. Anand, Ramanjit S Bagga, Jawed Fareed, Chi-Miau Pan, Samin K. Sharma, Merwin Richard> ;Journal of the American College of Cardiology. 2003 Feb 5
• 15 citations
  Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study).
  Annapoorna Kini, Merwin Richard, Javed Suleman, Nohelia Perez, Paul Lee, Edward A. Fisher, Mazullah Kamran, Jonathan D. Marmur, Samin K. Sharma> ;The American Journal of Cardiology. 2002 Sep 1
• 21 citations
  Antithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIa An Ex Vivo Human Study
  Eli I. Lev, Jonathan D. Marmur, Milan Zdravkovic, Julio I. Osende, Jonathan Robbins, Merwin Richard, Elisabeth Erhardtsen, Mikael S. Thomsen, A. Michael Lincoff, Juan ...> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2002 Jun 1
• 37 citations
  Testing Platelet Activation With a Shear-Dependent Platelet Function Test Versus Aggregation-Based Tests Relevance for Monitoring Long-Term Glycoprotein IIb/IIIa Inhib...
  Julio I. Osende, Valentin Fuster, Eli I. Lev, Daichi Shimbo, Ursula Rauch, Jonathan D. Marmur, Merwin Richard, David Varon, Juan J. Badimon> ;Circulation. 2001 Mar 20
• 14 citations
  Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function
  Eli I. Lev, Julio I. Osende, Merwin Richard, Jonathan Robbins, Oswaldo J. Rodriguez, Samin K. Sharma, Tim Jayasundera, Juan J. Badimon, Jonathan D. Marmur> ;Journal of the American College of Cardiology. 2001 Mar 1
• Join now to see all